SCHEMBL9822606

SCHEMBL9822606

OCc1cccc2c1CCC=C2

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRNE Q04844 1/20 0.33
APOBEC3G Q9HC16 1/20 0.31
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19314096 0.81 GABRA1 (0.38)
SCHEMBL13213096 0.81 PNMT (0.40)
SCHEMBL9822610 0.80
SCHEMBL28305445 0.79 HTR2B (0.35)
SCHEMBL9843338 0.78 GAA (0.34)
SCHEMBL16774069 0.77 ALDH1A1 (0.34)
SCHEMBL6749423 0.75 BCL2L1 (0.41)
SCHEMBL9822478 0.71 ADRA2A (0.36)
SCHEMBL19692682 0.71 PARP1 (0.34)
SCHEMBL31170847 0.71 PARP10 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2570414-A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues Bristol-Myers Squibb Company (US) 2013-03-20 EP disclosed
WO-2011025070-A1 ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING PATTERN USING THE COMPOSITION FUJIFILM CORPORATION (JP) 2011-03-03 WO disclosed
EP-0230967-B1 BENZAZECINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1991-10-23 EP disclosed
EP-0230967-A2 Benzazecine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-08-05 EP disclosed